Evidence map›Paper›PMID 30426183›Full record

ArticlePsychopharmacology2018

Comparison of local spectral modulation, and temporal correlation, of simultaneously recorded EEG/fMRI signals during ketamine and midazolam sedation.

Anna Forsyth, Rebecca McMillan, Doug Campbell, Gemma Malpas, Elizabeth Maxwell, Jamie Sleigh, Juergen Dukart, Joerg F Hipp, Suresh D Muthukumaraswamy

Abstract readComparative StudyControlled Clinical Trial
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anna ForsythSchool of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag, Auckland, 92019, New Zealand.
Rebecca McMillanSchool of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag, Auckland, 92019, New Zealand.
Doug CampbellDepartment of Anaesthesiology, Auckland District Health Board, Auckland, New Zealand.
Gemma MalpasDepartment of Anaesthesiology, Auckland District Health Board, Auckland, New Zealand.
Elizabeth MaxwellDepartment of Anaesthesiology, Auckland District Health Board, Auckland, New Zealand.
Jamie SleighDepartment of Anaesthesiology, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
Juergen DukartRoche Pharma Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center, F Hoffman La Roche, Basel, Switzerland.
Joerg F HippRoche Pharma Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center, F Hoffman La Roche, Basel, Switzerland.
Suresh D MuthukumaraswamySchool of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag, Auckland, 92019, New Zealand. sd.muthu@auckland.ac.nz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RATIONALE AND

objectivesThe identification of biomarkers of drug action can be supported by non-invasive brain imaging techniques, such as electroencephalography (EEG) and functional magnetic resonance imaging (fMRI), with simultaneous collection plausibly overcoming the limitations of either modality alone. Despite this, few studies have assessed the feasibility and utility of recording simultaneous EEG/fMRI in a drug study.

methodsWe used simultaneous EEG/fMRI to assess the modulation of neural activity by ketamine and midazolam, in a placebo-controlled, single-blind, three-way cross-over design. Specifically, we analysed the sensitivity and direction of the spectral effects of each modality and the temporal correlations between the modulations of power of the common EEG bands and the blood-oxygen-level-dependent (BOLD) signal. RESULTS AND

conclusionsDemonstrating feasibility, local spectral effects were similar to those found in previous non-simultaneous EEG and fMRI studies. Ketamine administration resulted in a widespread reduction of BOLD fractional amplitude of low frequency fluctuations (fALFF) and a diverse pattern of effects in the different EEG bands. Midazolam increased fALFF in occipital, parietal, and temporal areas, and frontal delta and beta EEG power. While EEG spectra were more sensitive to pharmacological modulations than the fALFF bands, there was no clear spatial relationship between the two modalities. Additionally, ketamine modulated the temporal correlation strengths between the theta EEG band and the BOLD signal, whereas midazolam altered temporal correlations with the alpha and beta bands. Taken together, these results demonstrate the utility of simultaneous recording: each modality provides unique insights, and combinatorial analyses elicit more information than separate recordings.

Indexed as

Magnetic Resonance ImagingAdultAnalgesicsBrainBrain MappingCross-Over StudiesElectroencephalographyHumansHypnotics and SedativesKetamineMaleMidazolamSingle-Blind MethodTime FactorsYoung AdultAnalgesicsHypnotics and SedativesKetamineMidazolamElectroencephalographyFrequency analysisFunctional magnetic resonance imagingKetamineMidazolamSimultaneous EEG/fMRI

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.